Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 13
Phase 22

Trial Status

Completed2
Terminated1

Role Distribution

Principal Investigator2
Other Roles1
PI Rate67%

Activity Timeline

Clinical Trials (3)

NCT03815942Phase 1/2Terminated
VAccination in Early and ADvanced Prostate caNCEr
Castration-resistant Prostate CancerIntermediate Risk Prostate Cancer
StudydirectorStart date: 2018-12-10
NCT02252640Phase 1/2Completed
A Safety and Efficacy Study of Concomitant Administration of ChAd63/MVA ME-TRAP + RTS,S
Plasmodium Falciparum Malaria
Principalinvestigator

Research Network

Collaboration Network

5 collaborators·10 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Andrew Protheroe

Nuffield Department of Surgical Sciences, Oxford University Hospitals NHS Foundation Trust

Related
1 trials

Shared therapeutic areas:

Castration-Resistant Prostate CancerIntermediate Risk Prostate Cancer

Worked with same sponsors:

Barinthus BiotherapeuticsUniversity of Oxford
Collaborated on 1 trial
Similarity Score24%

Freddie Hamdy

Nuffield Department of Surgical Sciences, Oxford University Hospitals NHS Foundation Trust

Related
1 trials

Shared therapeutic areas:

Castration-Resistant Prostate CancerIntermediate Risk Prostate Cancer

Worked with same sponsors:

Barinthus BiotherapeuticsUniversity of Oxford
Collaborated on 1 trial
Similarity Score24%

Peter Hoskin

Department of Oncology, The Christie NHS Foundation Trust

Related
1 trials

Shared therapeutic areas:

Castration-Resistant Prostate CancerIntermediate Risk Prostate Cancer

Worked with same sponsors:

Barinthus BiotherapeuticsUniversity of Oxford
Collaborated on 1 trial
Similarity Score24%

Mark Tuthill

Oxford Cancer and Haematology Centre, Oxford University Hospitals NHS Foundation Trust

Related
1 trials

Shared therapeutic areas:

Castration-Resistant Prostate CancerIntermediate Risk Prostate Cancer

Worked with same sponsors:

Barinthus BiotherapeuticsUniversity of Oxford
Collaborated on 1 trial
Similarity Score24%

Peter Aaby, Professor

Bandim Health Project

Related
5 trials

Shared therapeutic areas:

MalariaMalaria, Falciparum
Similarity Score15%

Rick M Fairhurst, M.D.

National Institute of Allergy and Infectious Diseases (NIAID)

Related
8 trials

Shared therapeutic areas:

MalariaMalaria, Falciparum
Similarity Score15%

Adrian V S Hill, MD

University of Oxford

Related
5 trials

Shared therapeutic areas:

Malaria, FalciparumMalaria

Worked with same sponsors:

University of Oxford
Similarity Score15%

Francesco Grandesso, MSc

Epicentre

Related
3 trials

Shared therapeutic areas:

Malaria, FalciparumMalaria
Similarity Score15%

Mark Rowland, Phd

London School of Hygiene and Tropical Medicine

Related
5 trials

Shared therapeutic areas:

MalariaMalaria, Falciparum
Similarity Score15%

Paul Milligan, PhD

London School of Hygiene and Tropical Medicine

Related
4 trials

Shared therapeutic areas:

Malaria
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT03815942Phase 1/2StudyDirector

VAccination in Early and ADvanced Prostate caNCEr

Castration-resistant Prostate CancerIntermediate Risk Prostate Cancer
Terminated
NCT01364883Phase 1PrincipalInvestigator

Safety and Immunogenicity of Novel Vaccination Schedules With Malaria Vaccines AdCh63 ME-TRAP and MVA ME-TRAP

Malaria
Completed
NCT02252640Phase 1/2PrincipalInvestigator

A Safety and Efficacy Study of Concomitant Administration of ChAd63/MVA ME-TRAP + RTS,S

Plasmodium Falciparum Malaria
Completed

All 3 trials loaded